On Aug. 26, the Mazzoni Center Board of Directors announced the appointment of Simon J. Trowell as the organization’s new Chief Executive Officer, following a national search process. “Simon brings a rare combination of scientific expertise, global leadership experience, and a deep commitment to community health and equity,” said Dr. Jeff Doucette, president of Mazzoni […] The post Mazzoni Center appoints Simon J. Trowell as Chief Executive Officer appeared first on Philadelphia Gay N...| Philadelphia Gay News
DREAMM-7-studien til GSK demonstrerte solide 36,6 måneders median progresjonsfri overlevelse hos myelomatose-pasienter som fikk Blenrep-kombinasjon. – Veldig spennende å se at dette faktisk er et mer effektivt medikament enn daratumumab, sier hematolog Fredrik Schjesvold.| www.healthtalk.no
GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.| Labiotech.eu